TET1 potently inhibited canonical Wnt/β‐catenin signalling by demethylating and upregulating two upstream antagonists of this pathway, SFRP2 and DKK1, which was associated with inhibition of EMT and cancer cell metastasis.39 The gene discussed is SFRP2; the disease is cancer.